Actuate Financial Statements From 2010 to 2026

ACTU Stock   5.52  0.23  4.00%   
Analyzing historical trends in various income statement and balance sheet accounts from Actuate Therapeutics' financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Actuate Therapeutics' valuation are summarized below:
Market Capitalization
136.7 M
Earnings Share
(3.11)
There are currently eighty-five fundamental signals for Actuate Therapeutics Common that can be evaluated and compared over time across rivals. All traders should validate Actuate Therapeutics' prevailing fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. Enterprise Value is likely to drop to about 102 M in 2026
Check Actuate Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Actuate Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 191.9 K, Interest Income of 220.7 K or Depreciation And Amortization of 2.6 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.4 K. Actuate financial statements analysis is a perfect complement when working with Actuate Therapeutics Valuation or Volatility modules.
  
Build AI portfolio with Actuate Stock
Check out the analysis of Actuate Therapeutics Correlation against competitors.

Actuate Therapeutics Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets8.7 M8.4 M17.4 M
Slightly volatile
Short and Long Term Debt Total324 K364.5 K397.8 K
Slightly volatile
Other Current Liabilities4.6 M7.9 MM
Slightly volatile
Total Current Liabilities7.4 M10.1 M5.3 M
Slightly volatile
Accounts PayableM1.7 M2.2 M
Very volatile
Cash8.5 M7.8 M17.3 M
Slightly volatile
Cash And Short Term Investments8.5 M7.8 M17.3 M
Slightly volatile
Common Stock Shares Outstanding18.2 M22.4 M15.9 M
Slightly volatile
Liabilities And Stockholders Equity8.7 M8.4 M17.4 M
Slightly volatile
Non Current Liabilities Total352.1 K370.6 K6.7 M
Pretty Stable
Other Current Assets683.8 K651.2 K139.8 K
Slightly volatile
Other Stockholder Equity160 M152.4 M30.3 M
Slightly volatile
Total Liabilities10.1 M10.6 M12.1 M
Slightly volatile
Total Current Assets8.7 M8.3 M17.4 M
Slightly volatile
Capital Stock24.1523.05.5971
Slightly volatile
Common Stock24.1523.06.3618
Slightly volatile
Non Currrent Assets Other88.4 K99.5 K108.6 K
Slightly volatile

Actuate Therapeutics Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Net Interest Income191.9 K234.1 K63.5 K
Slightly volatile
Interest Income220.7 K255.6 K82.5 K
Slightly volatile
Depreciation And Amortization2.6 M2.5 M488 K
Slightly volatile
Interest Expense28.8 K21.5 K19 K
Slightly volatile
Selling General AdministrativeM7.5 M4.2 M
Slightly volatile
Other Operating Expenses25.8 M28.9 M21.6 M
Slightly volatile
Research Development20.8 M21.5 M17.4 M
Slightly volatile
Total Operating Expenses25.8 M28.9 M21.6 M
Slightly volatile
Income Tax Expense640720786
Slightly volatile

Actuate Therapeutics Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation2.4 M2.3 M919.3 K
Slightly volatile
Change In Working Capital1.4 M990.1 K1.7 M
Slightly volatile
Begin Period Cash Flow2.5 M2.7 M16.2 M
Slightly volatile
Issuance Of Capital Stock17.4 M27.6 M19 M
Very volatile
Total Cash From Financing Activities18.7 M31.7 M19.5 M
Pretty Stable
End Period Cash Flow8.5 M7.8 M17.3 M
Slightly volatile
Sale Purchase Of Stock388.1 K436.7 K476.6 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Average PayablesM3.1 M2.8 M
Slightly volatile
Cash Per Share0.740.511.1513
Slightly volatile
Income Quality0.940.920.8829
Very volatile
Net Debt To EBITDA0.540.390.8454
Slightly volatile
Current Ratio2.271.23.8961
Slightly volatile
Debt To Equity0.02180.02460.0268
Slightly volatile
Debt To Assets0.01580.01780.0194
Slightly volatile
Ebt Per Ebit0.820.980.9909
Pretty Stable
Long Term Debt To Capitalization0.02130.02390.0261
Slightly volatile
Total Debt To Capitalization0.02130.02390.0261
Slightly volatile
Debt Equity Ratio0.02180.02460.0268
Slightly volatile
Quick Ratio2.271.23.8961
Slightly volatile
Net Income Per E B T0.80.90.9824
Slightly volatile
Cash Ratio2.241.133.8802
Slightly volatile
Debt Ratio0.01580.01780.0194
Slightly volatile

Actuate Therapeutics Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap110.5 M139.8 M130.5 M
Pretty Stable
Enterprise Value102 M132 M113.5 M
Slightly volatile

Actuate Fundamental Market Drivers

About Actuate Therapeutics Financial Statements

Actuate Therapeutics shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Actuate Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Actuate Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Actuate Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Actuate Stock Analysis

When running Actuate Therapeutics' price analysis, check to measure Actuate Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Actuate Therapeutics is operating at the current time. Most of Actuate Therapeutics' value examination focuses on studying past and present price action to predict the probability of Actuate Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Actuate Therapeutics' price. Additionally, you may evaluate how the addition of Actuate Therapeutics to your portfolios can decrease your overall portfolio volatility.